PBH Logo

Prestige Consumer Healthcare Inc. (PBH) 

NYSE
Market Cap
$4.14B
Sector
Healthcare
Industry
Medical—Distribution
Rank in Sector
374 of 774
Rank in Industry
6 of 8

Largest Insider Buys in Sector

PBH Stock Price History Chart

PBH Stock Performance

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear …

Insider Activity of Prestige Consumer Healthcare Inc.

Over the last 12 months, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $18M worth of Prestige Consumer Healthcare Inc. stock.

On average, over the past 5 years, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $6.81M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,500 shares for transaction amount of $50,850 was made by P'Pool William (SVP, Gen Counsel & Corp Sec.) on 2018‑02‑12.

List of Insider Buy and Sell Transactions, Prestige Consumer Healthcare Inc.

2024-11-19SaleChief Executive Officer
10,875
0.0221%
$82.60$898,2410.00%
2024-11-18SaleChief Executive Officer
82,237
0.1686%
$82.56$6.79M-0.27%
2024-11-12SaleChief Financial Officer
24,686
0.0502%
$82.01$2.02M+0.89%
2024-11-12SaleSee Remarks
8,987
0.0183%
$81.85$735,586+0.89%
2024-11-12SaleSVP Quality & Regulatory
9,885
0.0201%
$81.97$810,266+0.89%
2024-11-12SaleEVP, Marketing & Sales
9,063
0.0184%
$82.00$743,166+0.89%
2024-03-01SaleSVP Quality & Regulatory
172
0.0003%
$70.42$12,112+0.57%
2024-02-28SaleSVP Quality & Regulatory
662
0.0013%
$70.30$46,537+1.34%
2024-02-27SaleSVP Quality & Regulatory
1
<0.0001%
$70.00$70+0.92%
2024-02-26SaleSVP Quality & Regulatory
9,677
0.0196%
$70.43$681,597+0.72%
2024-02-23SaleSVP Quality & Regulatory
11
<0.0001%
$70.00$770+1.08%
2024-02-15SaleEVP, Marketing & Sales
15,549
0.0319%
$69.11$1.07M+2.38%
2024-02-14SaleSee remarks
26,019
0.0523%
$67.90$1.77M+3.99%
2024-02-14SaleChief Financial Officer
30,019
0.0608%
$68.35$2.05M+3.99%
2024-02-08SaleSVP Quality & Regulatory
5,336
0.0118%
$69.00$368,184+1.96%
2023-09-14SaleSVP Quality & Regulatory
2,540
0.0051%
$58.92$149,657+10.27%
2023-08-08SaleChief Executive Officer
32,800
0.0673%
$65.57$2.15M-2.47%
2023-05-24SaleChief Financial Officer
44,011
0.0894%
$60.07$2.64M+1.70%
2023-05-19SaleEVP, Marketing & Sales
17,194
0.0346%
$60.27$1.04M+0.30%
2023-05-15SaleSVP Quality & Regulatory
8,154
0.0164%
$58.80$479,455+2.59%

Insider Historical Profitability

11.59%
Lombardi Ronald M.Chief Executive Officer
320952
0.6496%
$83.70214+27.81%
P'Pool WilliamSee Remarks
20058
0.0406%
$83.7014+6.17%
Mann Peterdirector
440390
0.8914%
$83.7023<0.0001%
Anderson PeterChief Financial Officer
359761
0.7282%
$83.7011<0.0001%
Butler GerardChief Sales Officer
289172
0.5853%
$83.7021+12.53%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$633.54M17.588.73M-3.72%-$24.48M0.01
The Vanguard Group$416.64M11.565.74M-0.24%-$1.03M0.01
Dimensional Fund Advisors$229M6.353.16M-8.11%-$20.2M0.06
Macquarie Group$211.87M5.882.92M-4.66%-$10.35M0.19
Ariel Investments$185.83M5.162.56M+0.2%+$378,327.841.83
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.